To test if RNF6 upregulation could render RB cells resistant to anti-cancer drugs besides carboplatin, Y-79 and SO-Rb50 cells were first overexpressed with RNF6 and then their sensitivities to carboplatin, vincristine and etoposide were assessed. The gene discussed is RNF6; the disease is cancer.